These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32206959)

  • 1. Comment on "Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy".
    Coban E
    Int Urol Nephrol; 2020 Sep; 52(9):1703. PubMed ID: 32206959
    [No Abstract]   [Full Text] [Related]  

  • 2. Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy.
    Życzkowski M; Kaletka Z; Rajwa P; Rempega G; Stelmach P; Bogacki R; Łach-Wojnarowicz O; Paradysz E
    Int Urol Nephrol; 2020 May; 52(5):885-891. PubMed ID: 31953718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mean platelet volume to lymphocyte ratio may not be a marker for overall survival in non-metastatic clear cell renal cell carcinoma patients treated with nephrectomy.
    Beyan C; Beyan E
    Int Urol Nephrol; 2020 Aug; 52(8):1453-1454. PubMed ID: 32140898
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic value of preoperative lymphocyte to monocyte ratio in patients with nonmetastatic clear cell renal cell carcinoma.
    Chang Y; Fu Q; Xu L; Zhou L; Liu Z; Yang Y; Lin Z; Xu J
    Tumour Biol; 2016 Apr; 37(4):4613-20. PubMed ID: 26508025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of preoperative thrombocytosis in patients who underwent radical nephrectomy for nonmetastatic renal cell carcinoma.
    Choi JY; Ko YH; Song PH
    Investig Clin Urol; 2016 Sep; 57(5):324-9. PubMed ID: 27617313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial Comment to Proportion of patients eligible for adjuvant immunotherapy in nonmetastatic clear-cell renal-cell carcinoma treated with radical or partial nephrectomy.
    Naiki T; Yasui T
    Int J Urol; 2022 Oct; 29(10):1237-1238. PubMed ID: 36094781
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy.
    Peng D; Zhang CJ; Tang Q; Zhang L; Yang KW; Yu XT; Gong Y; Li XS; He ZS; Zhou LQ
    BMC Urol; 2018 Mar; 18(1):20. PubMed ID: 29544476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood Platelet Volume Represents a Novel Prognostic Factor in Patients with Nonmetastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic Scores.
    Seles M; Posch F; Pichler GP; Gary T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
    J Urol; 2017 Dec; 198(6):1247-1252. PubMed ID: 28716649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial Comment to Contact with renal sinus is associated with poor prognosis in surgically treated pT1 clear cell renal cell carcinoma.
    Teishima J
    Int J Urol; 2020 Aug; 27(8):662. PubMed ID: 32578259
    [No Abstract]   [Full Text] [Related]  

  • 10. Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomy.
    Viers BR; Houston Thompson R; Boorjian SA; Lohse CM; Leibovich BC; Tollefson MK
    Urol Oncol; 2014 Nov; 32(8):1277-84. PubMed ID: 25017696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can preoperative neutrophil lymphocyte ratio predict malignancy in patients undergoing partial nephrectomy because of renal mass?
    Gorgel SN; Ozer K; Kose O; Dindar AS
    Int Braz J Urol; 2018; 44(3):461-466. PubMed ID: 29211406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment to postoperative renal function after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease: a comparison with radical nephrectomy.
    Nohara T
    Int J Urol; 2011 Jun; 18(6):477. PubMed ID: 21599761
    [No Abstract]   [Full Text] [Related]  

  • 13. Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer.
    Pecoraro A; Palumbo C; Knipper S; Mistretta FA; Tian Z; Shariat SF; Saad F; Briganti A; Fiori C; Porpiglia F; Karakiewicz PI
    J Urol; 2019 Dec; 202(6):1120-1126. PubMed ID: 31347950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes.
    Albisinni S; Pretot D; Al Hajj Obeid W; Aoun F; Quackels T; Peltier A; Roumeguère T
    Prog Urol; 2019; 29(8-9):423-431. PubMed ID: 31196826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Followup of neutrophil-to-lymphocyte ratio and recurrence of clear cell renal cell carcinoma.
    Ohno Y; Nakashima J; Ohori M; Gondo T; Hatano T; Tachibana M
    J Urol; 2012 Feb; 187(2):411-7. PubMed ID: 22177153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial comment to cytoreductive nephrectomy for pT3b-T4 M1 renal cell carcinoma in 39 patients: single center analysis.
    O'Malley RL
    Int J Urol; 2012 Sep; 19(9):879-80. PubMed ID: 22672656
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial Comment to Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.
    Eto M
    Int J Urol; 2014 Apr; 21(4):358. PubMed ID: 24118209
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment to "Predictors of benign histology in clinical T1a renal cell carcinoma tumors undergoing partial nephrectomy".
    Izumi K
    Int J Urol; 2014 Jan; 21(1):103. PubMed ID: 23634777
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Healy KA; Marshall FF; Ogan K
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1295-304. PubMed ID: 16925495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.